Current therapy for asthma: Time for a change?

Journal of Pharmacy and Pharmacology

Volumn 49, Issue SUPPL. 3, 1997, Pages 13-16

  Barnes, Neil C ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHLORIDE CHANNEL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; FLUTICASONE PROPIONATE; FORMOTEROL; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL SODIUM; OXITROPIUM BROMIDE; PREDNISOLONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; META ANALYSIS; MORTALITY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; SIDE EFFECT; T LYMPHOCYTE;

ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS;

EID: 0030948801     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Alexander, A. G., Barnes, N. C. (1997) Immunosuppressive Agents in Pulmonary Pharmacology and Therapeutics. In: Leff, A. R. (ed.), McGraw Hill, New York
2. Alexander, A. G., Barnes, N. C., Kay, A. B. (1992) Trial of cyclosporin A in corticosteroid dependent chronic severe asthma. Lancet 339: 324-328
3. Barnes, P. J., Adcock, I. M. (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14: 436-441
4. Barnes, N. C., Kuitert, L. M. (1995) Drugs affecting the leukotriene pathway in asthma. Br. J. Clin. Pract. 49: 262-266
5. Barnes, P. I., Greening, A. P., Crompton, G. K. (1995) Glucorticoid resistance in asthma. Am. J. Respir. Crit. Care Med. 152: 5125-5142
6. Barnes, N. C., Black, B., Syrett, N. (1996) Reduction of exacerbations of asthma in multinational clinical trials with zafirlukast (Accolate). Am. J. Respir. Crit. Care Med. 153 (Suppl. 4): A802
7. British Thoracic Society (1990) Guidelines for management of asthma in adults: II - acute severe asthma. Br. Med. J. 301: 767-800
8. Calhoun, W. J., Lavins, B., Glass, M. (1995) Effect of accolate (zafirlukast) on bronchoalveolar lavage fluid (BAL) after segmental cutigen provocation (SBP) in patients with mild to moderate asthma. Am. J. Respir. Crit. Care Med. 151 (Suppl. 4): A42 (abstract)
9. Chervinsky, P., Bronsky, E., Dockhorn, R. (1991) Fluticasone proprionate (FP) aerosol in asthma. J. Allergy Clin. Immunol. 87 (1 Part 2): 255 (Abstract 464)
10. Corrigan, C. J., Brown, P., Barnes, N. C., Szefler, S. J., Tsai, J. J., Frew, A. J., Kay, A. B. (1991a) Corticosteroid resistance in chronic asthma (1) corticosteroid bioavailability, nuclear receptor characteristics and inhibition of peripheral blood T-cell proliferation by corticosteroids in vitro. Am. Rev. Respir. Dis. 144: 1016-1025
11. Corrigan, C. J., Brown, P., Barnes, N. C., Tsai, J. J., Frew, J. J., Kay, A. B. (1991b) Corticosteroid resistance in chronic asthma (2) peripheral blood T-lymphocyte activation and inhibition of lymphokine elaboration by corticosteroids and cyclosporin A. Am. Rev. Respir. Dis. 144: 1026-1032
12. Dahl, R., Lundback, B., Malo, J., Mazza, J. A., Nieminen, M. M., Saarelainen, P., Barnade, H. (1993) A dose-ranging study of fluticasone proprionate in adult patients with moderate asthma. Chest 104: 1352-1358
13. d'Alonzo, G. E., Nathan, R. A., Herochowicz, S., Morris, R. J., Patno, P., Rennard, S. I. (1994) Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. J. Am. Med. Assoc. 271: 1412-1416
14. Ernst, P., Spitzer, W. O., Suissa, S., (1992). Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. J. Am. Med. Assoc. 268: 3462-3464
15. Fjellbirkeland, L., Gulsvik, A., Palmer, J. B. D. (1994) The efficacy of inhaled salmeterol and individually dose-titrated, sustained release theophylline in patients with asthma. Respir. Med. 88: 599-607
16. Geddes, D. M. (1992) Inhaled corticosteroids: benefits and risks. Thorax 47: 404-407
17. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N. Engl. J. Med. 325: 388-392
18. Hill, J. M., Tattersfield, A. E. (1995) Corticosteroid sparing agents in asthma. Thorax 50: 577-582
19. Howarth, P. M. (1991) The investigation of the non-bronchodilator properties of asthma therapies in asthma. Eur. Respir. J. 4: 3995
20. Larsson, L. (1996) The status of asthma in Sweden. Respir. Ther. Int. 95-96
21. Littenburg, B. (1988) Aminophylline treatment in severe acute asthma. A meta-analysis. J. Am. Med. Assoc. 259: 1678-1684
22. Lock, S., Kay, A. B., Barnes, N. C. (1996) Double-bind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Respir. Crit. Care Med. 153: 509-514
23. Noonan, M. J., Chervinsky, P., Weisberg, S. C. (1994) Fluticasone proprionate aerosol therapy permits reductions of prednisolone while improving pulmonary function and asthma symptoms (abstract). Am. J. Respir. Crit. Care Med. 149 (Suppl.): A214
24. 2-agonists in asthma. N. Engl. J. Med. 327: 1204-1208
25. Pearlman, D. S., Chervinsky, P., LaForce, C., Seltzer, J. M., Southern, D. L., Kemp, J. P., Dockhorn, R. J., Grossman, J., Liddle, R. F., Yancey, S. W. (1992) A comparison of salmeterol with albuterol in the treatment of mild to moderate asthma. N. Engl. J. Med. 327: 1420-1425
26. - channels by acute allergic drugs. Biochem. Biophys. Res. Commun. 188: 957-963
27. Sears, M. R., Taylor, D. R., Print, C. G., Lake, D. C., Li, Q. Q., Flannery, E. M., Yates, D. M., Lucas, M. K., Herbison, G. P. (1990) Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336: 1391-1396
28. Sihra, B. S., Durham, S. R., Walker, S. M. (1996) Oral cyclosporin A inhibits the allergen-induced late asthmatic response and the associated increase in blood eosinophils. Am. J. Respir. Crit. Care Med. 153 (Suppl. 4): A533
29. Smith, M. J., Hodson, M. E. (1983) High dose beclomethasone inhaler in the treatment of asthma. Lancet i: 265-269
30. Spector, S. L., Kinsman, R. A., Mawhinney, M., Siegel, S. C., Rachelefsky, G. S., Katz, R. M., Rohr, A. S. (1986) Compliance of patients with asthma with an experimental aerosolized medication. Implications for controlled trials. J. Allergy Clin. Immunol. 77: 65-70
31. Spitzer, W. O., Suisa, S., Ernst, P., Horwitz, R. I., Habbick, B., Cockcroft, D., Boivin, J. F., McNutt, M., Buist, A. S., Rebuck, A. S. (1992) The use of β-agonists and the risk of death and near-death from asthma. N. Engl. J. Med. 326: 501-506
32. Torphy, T. J., Undem, B. J. (1991) Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46: 512-523
33. Warner, J. O., Gotz, M., Landau, L. I., Levison, H., Milner, A. D., Pedersen, S., Silverman, M. (1989) Management of asthma: a consensus statement. Arch. Dis. Child. 64: 1065-1079
34. Weiss, K. B., Georges, P. S., Hodgson, T. A. (1992) An economic evaluation of asthma in the United States. N. Engl. J. Med. 326: 862-866
35. Wong, C. S., Cooper, S., Britton, J. R., Tattersfield, A. E. (1993) Steroid sparing effect of nedocromil sodium in asthmatic patients on high doses of inhaled steroids. Clin. Exp. Allergy 23: 370-376
36. Zwillich, C. W., Neagley, S. R., Cicutto, L., White, D. P., Martin, R. J. (1989) Nocturnal asthma therapy: inhaled bitolterol versus sustained release theophylline. Am. Rev. Respir. Dis. 139: 470-474